Published in Biochem Biophys Res Commun on February 28, 1985
Voltage-gated calcium and potassium currents in megakaryocytes dissociated from guinea-pig bone marrow. J Physiol (1990) 0.98
Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets. Biochem J (1986) 0.89
Modulation of platelet-activating-factor-induced calcium influx and intracellular calcium release in platelets by phorbol esters. Biochem J (1987) 0.86
Ca(2+)-dependent aggregation of rabbit platelets induced by maitotoxin, a potent marine toxin, isolated from a dinoflagellate. Br J Pharmacol (1993) 0.84
Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity. Br J Pharmacol (2014) 0.79
Intracellular Ca2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G. Biochem J (1992) 0.78
PAR-1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium. Biochemistry (2006) 0.77
Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP. Biochem J (1990) 0.77
Inhibition of Ca2+ entry by Ca2+ overloading of intracellular Ca2+ stores in human platelets. J Physiol (1994) 0.76
Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists. Drug Des Devel Ther (2015) 0.76
Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. Br J Pharmacol (1995) 0.75
Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria. Br J Pharmacol (1990) 0.75
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
Stopped-flow kinetics of the interaction of the fluorescent calcium indicator Quin 2 with calcium ions. Biochem Biophys Res Commun (1984) 0.95
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. Br J Clin Pharmacol (1981) 0.90
Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol (1998) 0.90
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
Reaction of cysteine thiol groups with 1,3-propane sultone: S-3-sulphopropyl as a modifying group for protein chemistry. Int J Pept Protein Res (1974) 0.82
Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligands. Eur J Pharmacol (1984) 0.82
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Purification and chemical characterization of melittin and acetylated derivatives. Biochim Biophys Acta (1980) 0.80
Reduction of S-sulpho groups by tributylphosphine: an improved method for the recombination of insulin chains. Hoppe Seylers Z Physiol Chem (1975) 0.80
Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils. Br J Pharmacol (1998) 0.80
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1987) 0.80
Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol (1997) 0.80
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J Cardiovasc Pharmacol (1991) 0.79
4-pyridylmethyl, a thiol-protecting group suitable for the partial synthesis of proteins. Biochem J (1979) 0.79
Correlation between substance P content of primary sensory neurones and pain sensitivity in rats exposed to antibodies to nerve growth factor. Eur J Pharmacol (1982) 0.79
Studies on capacitative calcium entry in vascular smooth muscle cells by measuring 45CA2+ influx. J Recept Signal Transduct Res (1997) 0.78
Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radic Biol Med (1999) 0.77
Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. FEBS Lett (1986) 0.76
Reductive cleavage of S-sulfo groups with tributylphosphine. Methods Enzymol (1977) 0.76
Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity. Am J Hypertens (1991) 0.76
Antivasoconstrictor effects of isradipine. A quantitative approach in anesthetized rats and conscious rabbits. Am J Med (1989) 0.76
Sodium fluoride activation of human lymphocyte adenylate cyclase is reduced in old age. Br J Clin Pharmacol (1982) 0.75
2-Sulphobenzyl, a new solubilizing and reversible protecting group for cysteine in proteins. Its scope and limitations. Biochem J (1979) 0.75
Effects of calcium entry blockers on calcium fluxes in a vascular smooth muscle cell line. J Hypertens Suppl (1985) 0.75
Inactivation and solubilization of opiate receptors by phospholipases A2. Biochim Biophys Acta (1982) 0.75
Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol. Acta Physiol Scand (2002) 0.75
Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. J Cardiovasc Pharmacol (1993) 0.75
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75